Skip to main content

Table 1 Generalizability of the Study Sample

From: Factors affecting general practitioners’ decisions to adopt new prescription drugs – cohort analyses using Australian longitudinal physician survey data

 

National GPs

MABEL GPs

Final Sample

 

(N = 25,013)

(N = 1099)

(N = 576)

Male (%)

59

51

53

Age (mean)

54

51

53

State (%)

 New South Wales

33

26

27

 Victoria

25

29

30

 Queensland

20

18

17

 Western Australia

10

10

9

 Southern Australia

8

11

11

  1. Notes: National GPs’ data are from the Australian Medical Publishing Company which only includes variables listed here. Base year: 2013. We have 1099 GPs who signed consent forms to allow us to link their MABEL survey data with actual prescription and medical data in the Australian Pharmaceutical Benefits Scheme and Medical Benefits Schedule